BUCK NEIL ROBERT,LEUENBERGER BRUNO H.,STOECKLIN ELISABETH,URBAN KAI,WOLFRAM SWEN,CLAERHOUT WOUTER
申请号：
PL09710362
公开号：
PL2240182T3
申请日:
2009.02.12
申请国别(地区):
PL
年份:
2016
代理人:
摘要：
We disclose treating hyperglycemia in a human with 25-hydroxyvitamin D3 (calcifediol). Blood glucose is reduced to a level which is closer to normal than baseline. Vitamin D3 (cholecalciferol) may optionally be used together with 25-hydroxy vitamin D3. Forms and dosages of a pharmaceutical composition, as well as processes for manufacturing medicaments, are also disclosed.
